Meetings start at 8:30a.m. and are held remotely for the time being due to COVID-19. When in person meeting resume they are held at 677 East 12th Ave, Suite 500 in the main conference room (Mt. Hood - Room 506). 

Studies may be submitted at any time. Once a study is determined to require full board review and is ready for consideration by the fully convened IRB, the study is assigned to the next available committee meeting agenda.  

NOTE: Meetings will be canceled if there are no study submissions.

Frequently, the committee will request a representative of the research team attend the meeting in order to explain and/or clarify portions of the proposed research. In such instances, a Research Compliance Services (RCS) staff member will contact the investigator with the anticipated time the study will be considered.

The investigator in attendance should have their IRB materials accessible so they can answer questions that the board may ask. In some circumstances, they may also be asked to provide a brief 2-3 minute overview of the proposed research focusing on the procedures involving human subjects, the risks, and the measures in place to mitigate the risks. The floor will then be opened up to members of the board to ask any immediate questions. Afterwards, the investigator will be excused for the final deliberation and vote. An RCS Staff member will contact the investigator within three business days to convey the meeting outcome.